Table 4. Conclusion of the immunophenotyping assays
|
Pathology |
|
n |
% |
|
Reactive lymphocytosis |
5 |
12.8 |
|
|
Acute Leukemia |
|
4 |
10.3 |
|
Chronic lymphoid malignancies |
|
|
|
|
|
Myeloma or Plasma cell leukemia |
1 |
2.6 |
|
Waldenström disease |
1 |
2.6 |
|
|
NK proliferation |
1 |
2.6 |
|
|
Chronic lymphocytic leukemia |
8 |
20.5 |
|
|
Circulating phase of B cell non-Hodgkin’s lymphoma |
19 |
48.6 |
|
|
Total |
39 |
100 |
|